000			01443 a2200421 4500
005			20250516122816.0
264		0	_c20130207
008			201302s 0 0 eng d
022			_a1523-2859
040			_aNLM _beng _cNLM
245	0	0	_aA 4-drug combination (Stribild) for HIV. _h[electronic resource]
260			_bThe Medical letter on drugs and therapeutics _cNov 2012
300			_a95-6 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdenine _xanalogs & derivatives
650	0	4	_aAnti-HIV Agents _xtherapeutic use
650	0	4	_aCarbamates _xtherapeutic use
650	0	4	_aClinical Trials as Topic
650	0	4	_aCobicistat
650	0	4	_aDeoxycytidine _xanalogs & derivatives
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Approval
650	0	4	_aDrug Combinations
650	0	4	_aDrug Interactions
650	0	4	_aDrug Resistance, Multiple, Viral
650	0	4	_aEmtricitabine
650	0	4	_aHIV _xisolation & purification
650	0	4	_aHIV Infections _xdrug therapy
650	0	4	_aHumans
650	0	4	_aOrganophosphonates _xtherapeutic use
650	0	4	_aQuinolones _xtherapeutic use
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aTenofovir
650	0	4	_aThiazoles _xtherapeutic use
650	0	4	_aUnited States
650	0	4	_aUnited States Food and Drug Administration
773	0		_tThe Medical letter on drugs and therapeutics _gvol. 54 _gno. 1404 _gp. 95-6
999			_c22293466 _d22293466